Conformis, Inc.
CFMS · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $13 | $13 | $17 | $14 |
| % Growth | 1.4% | -26.3% | 26.4% | – |
| Cost of Goods Sold | $11 | $8 | $10 | $9 |
| Gross Profit | $2 | $5 | $7 | $5 |
| % Margin | 14.1% | 39.8% | 41.1% | 35.2% |
| R&D Expenses | $2 | $2 | $3 | $4 |
| G&A Expenses | $8 | $7 | $4 | $8 |
| SG&A Expenses | $12 | $12 | $11 | $13 |
| Sales & Mktg Exp. | $4 | $5 | $7 | $6 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14 | $15 | $14 | $17 |
| Operating Income | -$12 | -$9 | -$7 | -$12 |
| % Margin | -94.5% | -73.5% | -39% | -87% |
| Other Income/Exp. Net | -$1 | -$0 | $3 | -$3 |
| Pre-Tax Income | -$13 | -$10 | -$4 | -$15 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$13 | -$10 | -$4 | -$15 |
| % Margin | -99.9% | -74.6% | -21.3% | -110.3% |
| EPS | -1.78 | -1.32 | -0.51 | -2.1 |
| % Growth | -34.8% | -158.8% | 75.7% | – |
| EPS Diluted | -1.78 | -1.32 | -0.51 | -2.1 |
| Weighted Avg Shares Out | 7 | 7 | 7 | 7 |
| Weighted Avg Shares Out Dil | 7 | 7 | 7 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $0 | $0 | $1 |
| EBITDA | -$11 | -$9 | -$3 | -$14 |
| % Margin | -87.4% | -69.7% | -17.8% | -99.3% |